Institutional members access full text with Ovid®

Share this article on:

Arginine and Asymmetric Dimethylarginine in Pregnant Women With Major Depression

Raw, Alexander MD; Gallaher, Marcia MS; Powers, Robert W. PhD

doi: 10.1097/PSY.0000000000000077
Original Articles

Objective Depression has been associated with vascular dysfunction, which may be of particular relevance in pregnancy. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), and L-arginine play a critical role in vascular function. The objective of this study was to investigate differences in ADMA, SDMA, and L-arginine among pregnant women with major depression compared with pregnant women without depression.

Methods A case-control study was conducted in 21 depressed pregnant women and 42 matched controls. Maternal plasma ADMA, SDMA, and L-arginine were quantified, as well as C-reactive protein and urine excretion of ADMA, SDMA, L-arginine, and Arginase I.

Results Plasma L-arginine and ADMA levels were significantly lower in the first trimester in women with depression (mean [standard deviation = 37.0 [9.2] and 0.298 [0.06] μM, respectively) compared with matched controls (42.1 [11.4] and 0.336 [0.08] μM, p = .004 and p = .002, respectively) and across pregnancies (p < .001 both). Depressed pregnant women had higher levels of plasma C-reactive protein (7.5 [3.7] versus 5.1 [4.0] μg/ml, p = .027), but no differences in urine excretion of ADMA, SDMA, or L-arginine, or plasma levels of Arginase I (p > .10).

Conclusions Pregnant women with depression show lower plasma levels of L-arginine and ADMA. These differences are not explained by urinary excretion or Arginase I levels. The mechanism responsible for the observed differences in depressed pregnant women requires further research.

From the Department of Obstetrics & Gynecology and Reproductive Sciences (R.W.P.) and Magee-Womens Research Institute (A.R., M.G., R.W.P.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Address correspondence and reprint requests to Robert W. Powers, PhD, Department of Obstetrics & Gynecology and Reproductive Sciences, Magee-Womens Research Institute, University of Pittsburgh School of Medicine, 204 Craft Ave, Room A311, Pittsburgh, PA 15213. E-mail:

Received for publication March 4, 2013; revision received April 2, 2014.

Copyright © 2014 by American Psychosomatic Society
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website